Molecular Diagnostics
Molecular diagnostics is a highly specialized field that studies DNA, RNA, and molecular markers to understand how cancer behaves at a genetic level. By identifying changes within a tumor’s genetic code, it allows clinicians to move beyond traditional pathology and tailor treatment to the unique biology of each cancer.
A mutation is a change in a gene that alters how cells grow, divide, or function. While some mutations are harmless, others can drive cancer development. Certain mutations are considered actionable — meaning they directly influence clinical decisions. These actionable mutations help predict how aggressive a cancer may be, identify therapies that are likely to work, guide eligibility for clinical trials, and monitor treatment resistance over time.
At Apollo Athenaa, molecular diagnostics helps identify key actionable mutations such as BRCA1/2, PIK3CA, TP53, EGFR, KRAS, and CDK4/6 pathway alterations. By matching these genetic findings with targeted or personalized treatments, our specialists design smarter, safer, and more effective cancer care plans — ensuring each woman receives therapy guided by the biology of her disease, not just its location.
